Family history influences the tumor characteristics and prognosis of breast cancers developing during postmenopausal hormone therapy.

about

Association between ATM rs1801516 polymorphism and cancer susceptibility: a meta-analysis involving 12,879 cases and 18,054 controls

P2860

Q58544582-D2976CE7-A5F9-4FDA-9BAC-9536D2DC0451

P2860

Family history influences the tumor characteristics and prognosis of breast cancers developing during postmenopausal hormone therapy.

Item

http://www.wikidata.org/entity/Q48212258

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Family history influences the ...... ostmenopausal hormone therapy.

@en

Family history influences the ...... ostmenopausal hormone therapy.

@nl

type

Item

label

Family history influences the ...... ostmenopausal hormone therapy.

@en

Family history influences the ...... ostmenopausal hormone therapy.

@nl

prefLabel

Family history influences the ...... ostmenopausal hormone therapy.

@en

Family history influences the ...... ostmenopausal hormone therapy.

@nl

P1476

Family history influences the ...... ostmenopausal hormone therapy.

@en

P2093

Kirsi Aaltonen

http://www.w3.org/2001/XMLSchema#string

Kristiina Aittomäki

http://www.w3.org/2001/XMLSchema#string

Maria Faltinova

http://www.w3.org/2001/XMLSchema#string

Mervi Halttunen-Nieminen

http://www.w3.org/2001/XMLSchema#string

Päivi Heikkilä

http://www.w3.org/2001/XMLSchema#string

Rainer Fagerholm

http://www.w3.org/2001/XMLSchema#string

P2860

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families

Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone: Analyses of Data From 2 Women's Health Initiative Randomized Clinical Trials.

A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer.

Hormone replacement therapy before breast cancer diagnosis significantly reduces the overall death rate compared with never-use among 984 breast cancer patients

A population-based cohort study of HRT use and breast cancer in southern Sweden.

Menopausal hormone therapy in relation to breast cancer characteristics and prognosis: a cohort study

A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer.

Breast carcinoma developing in patients on hormone replacement therapy: a histological and immunohistological study.

P2888

s10689-017-0046-2

P31

scholarly article

P356

10.1007/S10689-017-0046-2

http://www.w3.org/2001/XMLSchema#string

P50

Heli Nevanlinna

Carl Blomqvist

P577

2017-10-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29019086

http://www.w3.org/2001/XMLSchema#string

Family history influences the tumor characteristics and prognosis of breast cancers developing during postmenopausal hormone therapy.

about

P2860

P2860

Family history influences the tumor characteristics and prognosis of breast cancers developing during postmenopausal hormone therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P31

P356

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P31

P356

P50

P577

P698